title: Hypersensitivity reactions to β-lactams: relevance of hapten-protein conjugates.
abstract: β-Lactams (BL) are the drugs most frequently involved in allergic reactions. They are classified according to their chemical structure as penicillins, cephalosporins, monobactams, carbapenems, and clavams. All BL antibiotics have a BL ring that is fused to a 5-member or 6-member ring (except in monobactams) and has 1, 2 or 3 side chains (except in clavams). Differences in chemical structure mean that a wide range of BLs are recognized by the immune system, and patients may experience clinical reactions to one BL while tolerating others. Diagnosis is based on skin and in vitro testing, although both display low sensitivity, possibly because they are based on drugs or drug conjugates that are not optimally recognized by the immune system. BLs are haptens that need to bind to proteins covalently to elicit an immune response. These drugs have a high capacity to form covalent adducts with proteins through nucleophilic attack of amino groups in proteins on the BL ring. Allergenic determinants have been described for all BLs, although benzylpenicillin is the most widely studied. Moreover, formation of BL-protein adducts is selective, as we recently demonstrated for amoxicillin, which mainly modifies albumin, transferrin, and immunoglobulin heavy and light chains in human serum. Given the complexity of BL allergy, understanding the immunological mechanisms involved and optimization of diagnostic methods require multidisciplinary approaches that take into account the chemical structures of the drugs and the carrier molecules, as well as the patient immune response.
authors.forename: A
authors.initials: A
authors.lastname: Ariza
authors.forename: C
authors.initials: C
authors.lastname: Mayorga
authors.forename: T D
authors.initials: TD
authors.lastname: Fernandez
authors.forename: N
authors.initials: N
authors.lastname: Barbero
authors.forename: A
authors.initials: A
authors.lastname: Martín-Serrano
authors.forename: D
authors.initials: D
authors.lastname: Pérez-Sala
authors.forename: F J
authors.initials: FJ
authors.lastname: Sánchez-Gómez
authors.forename: M
authors.initials: M
authors.lastname: Blanca
authors.forename: M J
authors.initials: MJ
authors.lastname: Torres
authors.forename: M I
authors.initials: MI
authors.lastname: Montanez
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001798:Blood Proteins / Q000276:immunology; D002352:Carrier Proteins / Q000276:immunology; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D006241:Haptens / Q000276:immunology*; D006801:Humans; D007159:Immunologic Tests; D047090:beta-Lactams / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D001798:Blood Proteins; D002352:Carrier Proteins; D006241:Haptens; D047090:beta-Lactams